- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Trex to acquire Trophy Radiologie
Trex Medical of Danbury, CT, announced last week that it plans to acquire Trophy Radiologie, a French manufacturer of dental and medical x-ray imaging systems. The agreement would give Trex an entrée into the dental market and would also expand
Trex Medical of Danbury, CT, announced last week that it plans to acquire Trophy Radiologie, a French manufacturer of dental and medical x-ray imaging systems. The agreement would give Trex an entrée into the dental market and would also expand the company's international distribution channels.
Trophy is a 52-year-old company that had revenues of $70 million for its 1997 fiscal year (end-August). The company claims to be the world's largest manufacturer of dental x-ray systems, including digital products.
Trex believes it can incorporate its digital technology into Trophy dental systems, and will also be able to use Trophy's medical imaging distribution system outside the U.S. For example, Trophy has been active in the Asian market for nearly 20 years. The acquisition requires regulatory and shareholder approvals.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
